Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 19,709	$ 1,819
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	4,046	4,057
Amortization of deferred debt issuance costs	1,407	1,506
Amortization	13,992	13,877
Stock-based compensation	6,240	5,726
Deferred income taxes	1,865	(1,140)
Non-cash adjustment to fair value of contingent consideration liability	(6,545)	4,436
Increase (decrease) in cash flows from changes in assets and liabilities:
Accounts receivable	(908)	(20,666)
Inventories	(5,049)	(3,016)
Accounts payable	12,999	2,699
Accrued compensation and benefits	(19,829)	(5,722)
Other assets	(6,781)	(11,372)
Other liabilities	7,975	3,949
Net cash provided by (used in) operating activities	29,121	(3,847)
Cash flows from investing activities:
Purchases of property, plant and equipment	(2,035)	(4,254)
Net cash used in investing activities	(2,035)	(4,254)
Cash flows from financing activities:
Payments on revolving line of credit	(168,000)	(164,000)
Proceeds from revolving line of credit	254,000	173,000
Payments to redeem convertible notes	(70,000)	0
Payments related to contingent consideration	(26,928)	0
Dividends paid on common stock	(6,153)	(6,098)
Other, net	67	2,448
Net cash provided by (used in) financing activities	(17,014)	5,350
Effect of exchange rate changes on cash and cash equivalents	(513)	303
Net increase (decrease) in cash and cash equivalents	9,559	(2,448)
Cash and cash equivalents at beginning of period	24,296	28,942
Cash and cash equivalents at end of period	33,855	26,494
Non-cash investing and financing activities:
Dividends payable	$ 6,158	$ 6,113